"paper"

Despite its large use, recommendations for the use of brain F-18 FDG-PET in clinical practice were still lacking. The European Academy of Neurology (EAN) and the European Association of Nuclear Medicine (EANM) promoted a concerted action with 7 specialists from the two Societies and a group of facilitators in order to make the point on this issue. Extensive literature review and analysis of available data led, together with expert opinion (Delphi consensus), to deliver these recommendations that cover practically all the main brain neurodegenerative conditions causing cognitive impairment.

WFN website: www.wfneurology.org Adress for the WBD: wbd2018@wfneurology.org. Clean air for brain health Mohammad Wasay MD, FRCP, FAAN (Aga Khan University, Karachi, Pakistan)
Wolfgang Grisold MD (Secretary General, WFN, Vienna, Austria) A link between environment and health has long been… Continue Reading

        by Anna Sauerbier         Digital medicine and treatment development for brain disorders AZ, Lilly pull plug on Alzheimer’s disease trials France builds first Alzheimer’s ‘village’ in pioneering experiment Horizon Europe budget not big… Continue Reading

oland is located in Central Europe between the Baltic Sea in the north, and the Sudetes and the Carpathian Mountains in the south, the majority of the area laying in the basin of the Vistula and Oder rivers. The country is inhabited by about 38 million people, and in terms of the area, which exceeds 300,000. km2, Poland is classified as 63rd on Earth. Its neighbours are: Germany, the Czech Republic, Slovakia, Ukraine, Belarus, Lithuania and Russia.

Highlights and late breaking news session 19.06.2018 by Tim von Oertzen This session was chaired by the outgoing EAN president Prof Gunther Deuschl, the chair of the Programme Committee, Prof Paul Boon, the incoming EAN president Franz Fazekas and the… Continue Reading

The year of 1949 was a celebrating year for Neurosciences in Portugal, since our professor of Neurology Egas Moniz was awarded the Nobel Prize of Medicine and Physiology, an important recognition of his neuroscience research. This was a mark that very much inspired the interest of our medical school on neurosciences.

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!

  2017 was a remarkable year for EBC, thanks to the development of an increasing number of activities and new initiatives. In particular, the publication of EBC’s policy white paper on the “Value of Treatment for Brain Disorders in Europe”… Continue Reading

by Prof. Radu Tanasescu   Paper: Maggi et al. ‘Central Vein Sign Differentiates Multiple Sclerosis from Central Nervous System Inflammatory Vasculopathies’. Annals of Neurology. 2018;83:283–294. Outline: This paper shows for the first time that central vein assessment in white matter… Continue Reading

Epilepsy Center, Neurocenter, Kuopio University Hospital and Faculty of Health Sciences, School of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland

Gunhild Waldemar (GW): Can you please tell the EAN Pages readers about the goals of the BioMed Alliance and the criteria that need to be fulfilled in order to become a member of the BioMed Alliance? Axel Pries (AP): The Association’s principal goals and objectives are to promote the best interests and values of researchers, of healthcare professionals, and of non-for-profit medical associations and organisations across all medical disciplines in Europe, in those general areas of common interest.

David B. Vodušek (DBV): UEMS-Union Européenne des Médecins Spécialistes/European Union of Medical Specialists has already a long experience with accreditation of international CME in Europe. Please inform about the situation of CME in European countries. What are the differences between CME and CPD? Nathalie Paulus (NP): One of the aims of the UEMS has always been to try and harmonise CME/CPD in Europe. In this respect the UEMS regularly conducts surveys in order to explore the state of play of CME/CPD in Europe. The latest survey dates back to 2014.

It is with great gratitude and pleasure that I report my European Academy of Neurology Research Fellowship at the Clinical Department of Neurology, Medical University of Innsbruck. This 8-months experience (March-October 2017), performed under the supervision of Professor Markus Reindl, allowed me to join an excellent research center for the study of antibody-mediated disorders of the Central Nervous System.

Thank you for hosting applicants of the EAN Clinical Fellowship. How would you evaluate this EAN educational opportunity? The EAN Clinical Fellowship is an excellent opportunity for young neurologists and trainees, to focus on a specific clinical field, and learn / share experience with centres specialised in that field. It is also rewarding for us to meet young, enthusiastic fellows.